Q: I recently bought the following health care stocks: Merus, NHC, PHM and CRH Medical and they are all down a lot now, some as much as 40%. I’m not sure whether I should sell and take the losses or hold on? And why is health care selling off? I thought it usually did well in a recession?
Q: Big drop today on volume,continuing its drop.Is results coming out this week?Bought small portion @ $10.32,so now down 39%.Buy more,hold or sell?.Thanks for your normal great services & views.
Q: Hi folks,if no one else has asked,could please comment on Q results for Merus labs & going forward,would u rate it a buy,hold or sell. If already asked,please disregard,thanks, jb
Q: BNN had a special presentation on "What went wrong with PHM" last Friday. And BNN host Amber mentioned that PHM is mainly owned by retail investors. Do you know if this is a true statement? Thanks!
I see a lot of bio/medical service stocks are being taken to the woodshed today for reasons unknown. I plan on selling a bit of AYA and building my holding in GUD to a full position (5.1% of my total portfolio) and then not touching it for at least 3 years. What do you think?
Q: What do you think of the recent developments at Knight Therapeutics Inc? Their New Drug Submission has been accepted for review by Health Canada and they have entered into an exclusive distribution agreement with Ember Therapeutics.GUD seems to have dropped 7% in the last couple days on the news. It seems to me the news was positive but is there something I'm missing? Thank-you for your service.
Q: Hello Peter & Co,
A follow up on my previous question. SIS is classified as Industrials; is it because of its manufacturing side?
PM is classified as health
Thanks,
Antoine
Q: Another article on PHM in the Globe and Mail and again you've provided a negative quote which they've included. I'm dissapointed that you are adding to the negative sentiment on this stock which is in your growth portfolio and which many of your members have purchased, especially when the fundamentals of the company are still good.
Q: What are your thoughts on a share purchase at this time? Pozen has a new CEO guiding them who has a stellar reputation for packaging companies as attractive takeover targets.
Q: Hi,
Can you tell me why TRL has been declining lately? Have the fundamentals changed or is this just a case of investors bailing out in a tough market?
Thanks
Q: First I want to say what a great job Peter did today on BBN.I know you are not familiar with a number of US co. but was hoping you might have something on this co.Thanks
Q: Hi Peter, thanks for your good comments of PHM on BNN this evening. Indeed, it answered a few questions of mine regarding future acquisitions and financing. You have advised members to do nothing. Now my question is at what point investors can buy additional shares to average down? I normally don't like to average down. However, there is nothing wrong with Its fundamental. Should investors use average down strategy to take advantage of declined price? I see it has great value under a dollar. What's the fair value do you think PHM should be priced at considers its fundamental only? Thank you!
Q: Hi 5i Team, Still working on my rebalance after Portfolio Review. Catamaran is now taken over and my HEALTHCARE is CXR 2.9%, GUD, 0.7 and PLI 0.6% total 4.2%. Want to go to 5% and hold CXR, should I increase the other 2 or would you suggest something else? Appreciate your help always.
Q: I haven't seen a question about Biosyent in a couple of months, it's trading near its 52 week low. You indicated in May the fundamentals looked good, the price is still is dropping possibly due to the sector. I am considering taking a position at this time, please advise your thoughts.
Thanks
Jim